Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical Parameters

BACKGROUND: Radium-223 dichloride (Ra-223) is now frequently used to treat prostate cancer that has metastasized to bone, although patient selection continues to be suboptimal for determining who will benefit most from this novel treatment modality. MATERIALS AND METHODS: Seventy-nine patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shariftabrizi, Ahmad, Kothari, Shalin, George, Saby, Attwood, Kristopher, Levine, Ellis, Lamonica, Dominick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020806/
https://www.ncbi.nlm.nih.gov/pubmed/36651837
http://dx.doi.org/10.1093/oncolo/oyac245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020806/
https://www.ncbi.nlm.nih.gov/pubmed/36651837
http://dx.doi.org/10.1093/oncolo/oyac245

Ejemplares similares